National Hepatitis C Testing Policy May 2007
Appendix 2 Stakeholder consultation
The following stakeholders were provided with a consultation draft of this document for comment:
Australia:
Aboriginal Health and Medical Council (NSW)Australasian Professional Society on Alcohol and Other Drugs
Australasian Society for HIV Medicine
Australian Association of Pathology Practices
Australian Centre in Hepatitis and HIV Virology Research
Australian Divisions of General Practice
Australian Injecting and Illicit Drug Users’ League
Australian Liver Association
Australian Red Cross Blood Service
Australian Society for Infectious Diseases
Blood Borne Virus and Sexually Transmissible Infections Subcommittee (BBVSS) of the Australian Population Health Development Principle Committee (APHDPC)
Communicable Diseases Network Australia
Gastroenterological Society of Australia
Haemophilia Foundation Australia
HIV/AIDS and STIs Subcommittee of MACASHH
Indigenous Australians’ Sexual Health Committee of MACASHH
Medical Industry Association of Australia
National Association of Testing Authorities, Australia
National Coalition of Public Pathology
National Pathology Accreditation Advisory Council
National Serology Reference Laboratory, Australia
Public Health Association
Public Health Laboratory Network
Royal Australian and New Zealand College of Obstetricians and Gynaecologists
Royal Australian College of General Practitioners
Royal Australasian College of Physicians
Royal Australian College of Surgeons
Royal College of Pathologists of Australasia
RCPA QAP Pty Ltd (Serology QAP)
Turning Point Alcohol and Drug Centre
Transplantation Society of Australia and New Zealand
Therapeutic Goods Administration
New Zealand:
Ministry of HealthNew Zealand Hepatitis Foundation

